Navigation Links
VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
Date:10/10/2007

(NDA) to the U. S. Food and Drug Administration (FDA) in 2007 for Lenocta(TM) for the treatment of leishmaniasis.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties that could cause VioQuest's actual results and experiences to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These forward-looking statements concern the timing, progress and results of the clinical development, regulatory processes, and potential clinical trial initiations of Lenocta. These statements are often, but not always, made through the use of words or phrases such as anticipates, expects, plans, believes, intends, and similar words or phrases. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. These statements are subject to various risks and uncertainties and include the possibility that the results of clinical trials will not support VioQuest's claims, the possibility that VioQuest's development efforts relating to its product candidates, including Lenocta(TM), will not be successful, the inability to obtain regulatory approval of VioQuest's product candidates, VioQuest's reliance on third-party researchers to develop its product candidates, its lack of experience in developing and commercializing pharmaceutical products, and the possibility that its licenses to develop and commercialize its product candidates may be terminated. Additional risks are described in VioQuest's Annual Report on Form 10-KSB for the year ended December 31, 2006. VioQuest assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contact information:

Daniel Greenleaf

President and CEO

908-766-4400 ext. 115


SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014 Breast cancer will interrupt life ... who get a new diagnosis. The Commission for ... case managers to help those diagnosed with advanced ... physical, emotional and financial decisions that come with ... cost via the Commission,s online knowledge resource, the ...
(Date:11/18/2014)... 18, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... manuscript on Risk-Based Monitoring (RBM), " Evaluating ... Measure in Clinical Trials ," in the ... Regulatory Science  (TIRS) journal. Developed by TransCelerate,s ... the manuscript examines the value of Source ...
(Date:11/18/2014)... , Nov. 18, 2014   Rio Grande ... with University of Texas Health Science Center at ... Brownsville , has selected Wellcentive,s suite of ... providers in a four-county area to partner with hospitals ... health of their Medicaid and uninsured patient populations, initially ...
Breaking Medicine Technology:New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4
... N.J., April 25, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... Watson has entered into a definitive agreement to acquire privately ... a result of this acquisition, Watson will become the third ... of approximately $8 billion. Actavis, which as ...
... STAAR Surgical Company (NASDAQ: STAA ) today announced that ... 30, 2012 on Wednesday, May 2, 2012 after ... call and webcast on Wednesday, May 2, 2012 at 4:30 ... to discuss the Company,s first quarter 2012 results and recent corporate developments. ...
Cached Medicine Technology:Watson to Acquire Actavis Group for EUR4.25 Billion 2Watson to Acquire Actavis Group for EUR4.25 Billion 3Watson to Acquire Actavis Group for EUR4.25 Billion 4Watson to Acquire Actavis Group for EUR4.25 Billion 5Watson to Acquire Actavis Group for EUR4.25 Billion 6Watson to Acquire Actavis Group for EUR4.25 Billion 7Watson to Acquire Actavis Group for EUR4.25 Billion 8Watson to Acquire Actavis Group for EUR4.25 Billion 9STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast 2
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... is now creating picture-perfect smiles for patients in preparation ... are bonded to the fronts of teeth, look completely ... flaws. In certain situations, veneers are also valued for ... for most patients and can be used on one ...
(Date:11/21/2014)... 21, 2014 (HealthDay News) -- Scientists say they,ve mapped the ... from a British man,s brain, in hopes it might help ... 21 in the journal Genome Biology , the tapeworm ... of Chinese ethnicity. "This infection is so rare worldwide ... not diagnosed ... until the worm was pulled out from ...
(Date:11/21/2014)... 21, 2014 The Ohio Children’s Trust ... Ohio Chapter, American Academy of Pediatrics (Ohio AAP, ... education to parents and caregivers throughout Ohio. The new ... 30, 2015, provides $75,000 to continue the campaign that ... Trust Fund is excited to continue partnering with the ...
(Date:11/21/2014)... Midway through the research period for the ... Directory of Health Plans, preliminary data shows volatility in ... Plans is a comprehensive resource with enrollment data and ... The 2015 edition will be available in ... Databases Division, the company’s exclusive in-house research team, have ...
(Date:11/21/2014)... November 21, 2014 CDT PLUS! ... dental practice. It includes everything needed to process dental ... Coding with CDT , CDT 2015 codes are mandatory ... 1, 2014 - December 31, 2014. Dental professionals must ... services on dental claims. There are significant changes in ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2
... Being satisfied with your life can be good for your ... included almost 8,000 British civil servants, average age 49, who ... lives: romantic relationships, leisure activities, job, family, sex, standard of ... about six years, higher levels of overall life satisfaction were ...
... improvements in surgical care in early-stage lung cancer have ... according to a population-based study presented at the 14th ... the International Association for the Study of Lung Cancer ... lung cancer (NSCLC) patients increased by nearly 8 months ...
... diabetes, arthritis, chronic respiratory disorders and cancer represent the ... affect all age groups. The cost of treating these ... under-appreciated cause of poverty. In BioMed Central,s ... group of scientists and medical doctors have proposed an ...
... , TUESDAY, July 5 (HealthDay News) -- The timing and ... best customized for each woman, based on such factors as ... for all women based on age alone is not the ... Schousboe, medical director of research at Park Nicollet Health Services ...
... Researchers have identified when an important milestone in infants, ... situations. In a series of studies, the researchers ... in a different circumstance, but 16-month-olds could do so. ... begin learning how to learn," said Julie Hupp, lead ...
... -- ,A new study finds that painkillers widely used ... of atrial fibrillation, a heart rhythm disorder connected with ... Previous research has linked non-steroidal anti-inflammatory drugs ... to an increased risk for heart attacks and strokes, ...
Cached Medicine News:Health News:Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 2Health News:Mammogram Schedule Should Be Customized, Study Finds 2Health News:Mammogram Schedule Should Be Customized, Study Finds 3Health News:Infants learn to transfer knowledge by 16 months, study finds 2Health News:Infants learn to transfer knowledge by 16 months, study finds 3Health News:Painkillers May Raise Risk of Dangerous Heart Flutter 2
... network of door controllers, RoamAlert Integrity Plus ... the coverage area. These receivers pick up ... similar in size and shape, this tag ... RoamAlert ECO and RoamAlert Integrity in one ...
... Radio Frequency Identification (RFID) helps incorporate people ... into the healthcare value chain. The power ... us further automate and optimize business activities ... to tracking pharmaceutical inventories, RFID offers tremendous ...
VACUETTE PaediatricMulti-Sample Needle...
37°C incubator for DianaGel cards....
Medicine Products: